Research by Dr. Yen-Tyng Chen et al. Examine Links between HIV Medication Adherence and COVID-19 Vaccine Hesitancy

April 3, 2023

Abstract

Background: Although there is limited literature on medication adherence (including HIV care engagement) and COVID-19 vaccine hesitancy in general populations (i.e., non-sexual or gender minority populations), even less is known about whether HIV care engagement correlates with COVID-19 vaccine hesitancy among sexual and gender minorities, especially those from intersectional backgrounds. The objective of the current study was to examine if an association exists between HIV status neutral care (i.e., current pre-exposure prophylaxis [PrEP] or antiretroviral therapy [ART] use) and COVID-19 vaccination hesitancy among Black cisgender sexual minority men and transgender women at the initial peak of the pandemic. Methods: We conducted the N2 COVID Study in Chicago from 20 April 2020 to 31 July 2020 (analytic n = 222), including Black cisgender sexual minority men and transgender women who were vulnerable to HIV as well as those who were living with HIV. The survey included questions regarding HIV care engagement, COVID-19 vaccination hesitancy and COVID-19 related socio-economic hardships. Multivariable associations estimated adjusted risk ratios (ARRs) using modified Poisson regressions for COVID vaccine hesitancy adjusting for baseline socio-demographic characteristics and survey assessment time period. Results: Approximately 45% of participants reported COVID-19 vaccine hesitancy. PrEP and ART use were not associated with COVID-19 vaccine hesitancy when examined separately or combined (p > 0.05). There were no significant multiplicative effects of COVID-19 related socio-economic hardships and HIV care engagement on COVID-19 vaccine hesitancy. Conclusions: Findings suggest no association between HIV care engagement and COVID-19 vaccine hesitancy among Black cisgender sexual minority men and transgender women at the initial peak of the pandemic. It is therefore essential that COVID-19 vaccine promotion interventions focus on all Black sexual and gender minorities regardless of HIV care engagement and COVID-19 vaccine uptake is likely related to factors other than engagement in HIV status neutral care.

Keywords: HIV care engagementCOVID-19 vaccination hesitancyBlack cisgender sexual minority menBlack transgender women

Citation

Duncan, Dustin T., Su Hyun Park, Yen-Tyng Chen, Brett Dolotina, Wilder R. Worrall, Hillary Hanson, Mainza Durrell, Gustavo Arruda Franco, Stephen S. Morse, and John A. Schneider. 2023. “HIV Care Engagement Is Not Associated with COVID-19 Vaccination Hesitancy during the Initial Peak of the COVID-19 Pandemic among Black Cisgender Sexual Minority Men and Transgender Women in the N2 COVID Study” Vaccines 11, no. 4: 787. https://doi.org/10.3390/vaccines11040787

Recent Posts

Research Day 2026 Recap: Winners and Videos

The Bloustein School's 5th Annual Research Day took place in person at the Gov. James J. Florio Special Events Forum on Friday, April 3rd. The event was an opportunity for Bloustein students, faculty, and staff to showcase their research, receive feedback, and build...

2026 NJBIZ Health Care Power List includes Prof. Joel Cantor

Power List Methodology The power lists are compiled by the NJBIZ editorial staff based on our reporting throughout the past year with input from experts in a variety of fields and recommendations from our readers. The staff looks for people who have gained public...

NJSPL: How Demonstration Projects Strengthen Rapid Response Programs

By Leigh Ann Von Hagen., Analise Draghi & Greg Woltman Across New Jersey, communities are embracing faster, more flexible ways to make streets safer. Demonstration projects are short-term, low-cost installations that test street design changes. They have become a...